104 related articles for article (PubMed ID: 20530553)
1. A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesis.
Zumsteg A; Strittmatter K; Klewe-Nebenius D; Antoniadis H; Christofori G
Carcinogenesis; 2010 Aug; 31(8):1465-74. PubMed ID: 20530553
[TBL] [Abstract][Full Text] [Related]
2. Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
Zumsteg A; Caviezel C; Pisarsky L; Strittmatter K; García-Echeverría C; Hofmann F; Christofori G
Mol Cancer Res; 2012 Jun; 10(6):800-9. PubMed ID: 22562956
[TBL] [Abstract][Full Text] [Related]
3. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
[TBL] [Abstract][Full Text] [Related]
5. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
[TBL] [Abstract][Full Text] [Related]
6. Modulation of endocrine pancreas development but not beta-cell carcinogenesis by Sprouty4.
Jäggi F; Cabrita MA; Perl AK; Christofori G
Mol Cancer Res; 2008 Mar; 6(3):468-82. PubMed ID: 18337453
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.
Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G
Cancer Res; 2002 Jan; 62(2):603-8. PubMed ID: 11809716
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis.
Vasavada RC; Wang L; Fujinaka Y; Takane KK; Rosa TC; Mellado-Gil JM; Friedman PA; Garcia-Ocaña A
Diabetes; 2007 Nov; 56(11):2732-43. PubMed ID: 17686945
[TBL] [Abstract][Full Text] [Related]
9. A causal role for E-cadherin in the transition from adenoma to carcinoma.
Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G
Nature; 1998 Mar; 392(6672):190-3. PubMed ID: 9515965
[TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells.
Perl AK; Dahl U; Wilgenbus P; Cremer H; Semb H; Christofori G
Nat Med; 1999 Mar; 5(3):286-91. PubMed ID: 10086383
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
[TBL] [Abstract][Full Text] [Related]
13. Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function.
Kren A; Baeriswyl V; Lehembre F; Wunderlin C; Strittmatter K; Antoniadis H; Fässler R; Cavallaro U; Christofori G
EMBO J; 2007 Jun; 26(12):2832-42. PubMed ID: 17541405
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
16. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
17. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
18. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC
Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693
[TBL] [Abstract][Full Text] [Related]
19. A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization.
Peter C; Kielstein JT; Clarke-Katzenberg R; Adams MC; Pitsiouni M; Kambham N; Karimi MA; Kengatharan KM; Cooke JP
J Urol; 2007 Jun; 177(6):2342-6. PubMed ID: 17509355
[TBL] [Abstract][Full Text] [Related]
20. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
